Erythromycin is the founding macrolide antibiotic produced by Saccharopolyspora erythraea, inhibiting bacterial 50S ribosomal protein synthesis, used for respiratory and skin infections and as a promotility agent. Simson Pharma's Erythromycin reference standard and impurities support the comprehensive compendial testing this complex multi-component natural antibiotic demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Erythromycin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.